Benutzerspezifische Werkzeuge
Sie sind hier: Startseite → Collaborative Research Center 655 → Publications → B7-Illmer / Ehninger
© Startbild/Main Picture: Artwork NIH stem cell report, modified
 

B7: Selected publications

  • Ovcharenko D, Stölzel F, Poitz D, Fierro F, Schaich M, Neubauer A, Kelnar K, Davison T, Müller-Tidow C, Thiede C, Bornhäuser M, Ehninger G, Brown D, Illmer T (2011): miR-10a Overexpression is Associated with NPM1 Mutations and Mdm4 Downregulation in Intermediate-Risk Acute Myeloid Leukemia. Exp Hematol 2011 Jul 21. [Epub ahead of print]
  • Teichler S, Illmer T, Roemhild J, Ovcharenko D, Stiewe T, Neubauer A (2011): MicroRNA29a regulates the expression of the nuclear oncogene Ski. Blood 2011 Jun 17. [Epub ahead of print]
  • Jing D, Alakel N, Bornhäuser M, Ehninger G, Ordemann R (2010): SDF-1/CXCR4 blockade to mobilize hematopoietic progenitor cells from the placenta. Bone Marrow Transplant 45,1661-2. 
  •  Jing D, Fonseca A-V, Alakel N, Fierro FA, Muller K, Bornhäuser M, Ehninger G, Corbeil D and Ordemann R (2010): Hematopoietic stem cells in coculture with mesenchymal stromal cells - modelling the niche compartments in-vitro. Haematologica 95, 542-50.
  • Alakel N, Jing D, Muller K, Bornhauser M, Ehninger G, Ordemann R (2009): Direct contact with mesenchymal stromal cells affects migratory behavior and gene expression profile of CD133+ hematopoietic stem cells during ex vivo expansion. Exp Hematol. 37, 504-13.
  • Platzbecker U, Bornhauser M, Germing U, Stumpf J, Scott BL, Kroger N, Schwerdtfeger R, Bohm A, Kobbe G, Theuser C, Rabitsch W, Valent P, Sorror ML, Ehninger G, Deeg HJ (2008): Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS). Biol. Blood Marrow Transplant. 14, 1217-1225.
  • von Bonin M, Stolzel F, Goedecke A, Richter K, Wuschek N, Holig K, Platzbecker U, Illmer T, Schaich M, Schetelig J, Kiani A, Ordemann R, Ehninger G, Schmitz M, Bornhauser M (2009): Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 43, 245-51.
  • von Bonin M, Oelschlagel U, Radke J, Stewart M, Ehninger G, Bornhauser M, Platzbecker U (2008): Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab. Transplantation. 86, 875-879.
  • Schetelig J, Bornhauser M, Schmid C, Hertenstein B, Schwerdtfeger R, Martin H, Stelljes M, Hegenbart U, Schafer-Eckart K, Fussel M, Wiedemann B, Thiede C, Kienast J, Baurmann H, Ganser A, Kolb HJ, Ehninger G (2008): Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group. J. Clin. Oncol. 26, 5183-5191.
  • Bornhauser M, Illmer T, Oelschlaegel U, Schetelig J, Ordemann R, Schaich M, Hanel M, Schuler U, Thiede C, Kiani A, Platzbecker U, Ehninger G (2008): Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemia. Clin. Cancer Res. 14, 5585-5593.
  • Fierro FA, Brenner S, Oelschlaegel U, Jacobi A, Knoth H, Ehninger G, Illmer T, Bornhauser M (2008): Combining SDF-1/CXCR4 antagonism and chemotherapy in relapsed acute myeloid leukemia. Leukemia, in press.
  • Platzbecker U, Binder M, Schmid C, Rutt C, Ehninger G, Bornhauser M (2008): Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation. Haematologica. 93, 1276-1278.
  • Haentzschel I, Freiberg-Richter J, Platzbecker U, Kiani A, Schetelig J, Illmer T, Ehninger G, Schleyer E, Bornhauser M (2008): Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation. Bone Marrow Transplant. 42, 113-120.
  • Illmer T and Ehninger G (2007): FLT3 kinase inhibitors in the management of acute myeloid leukemia. Clin. Lymphoma Myeloma. 8 Suppl 1:S24-34., S24-S34.
  • Fierro FA, Taubenberger A, Puech PH, Ehninger G, Bornhauser M, Muller DJ, Illmer T (2008): BCR/ABL expression of myeloid progenitors increases beta1-integrin mediated adhesion to stromal cells. J. Mol. Biol. 377, 1082-1093.
  • Koch S, Jacobi A, Ryser M, Ehninger G, Thiede C (2008): Abnormal localization and accumulation of FLT3-ITD, a mutant receptor tyrosine kinase involved in leukemogenesis. Cells Tissues. Organs. 188, 225-235.
  • Schulze A, Schirutschke H, Oelschlagel U, Schmitz M, Fussel M, Wassmuth R, Ehninger G, Bornhauser M, Platzbecker U (2008): Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation. Exp. Hematol. 36, 378-389.
  • Goekkurt E, Stoehlmacher J, Stueber C, Wolschke C, Eiermann T, Iacobelli S, Zander AR, Ehninger G, Kroger N (2007): Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation. Anticancer Res. 27, 4377-4380.
  • Platzbecker U, Stoehlmacher J, Pabst C, Goekkurt E, Oelschlagel U, Schirutschke H, Holig K, Theuser C, Mogck U, Ehninger G, Bornhauser M (2008): Induction of Toll-like receptor 2 and 4 expression on CD4+ and CD8+ T cells in G-CSF-mobilized unrelated peripheral blood stem cell grafts during leukapheresis: impact on patient outcome. Leukemia 22, 1438-1440.
  • Wandt H, Schakel U, Kroschinsky F, Prange-Krex G, Mohr B, Thiede C, Pascheberg U, Soucek S, Schaich M, Ehninger G (2008): MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients. Blood. 111, 1855-1861.
  • Schmid C, Labopin M, Nagler A, Bornhauser M, Finke J, Fassas A, Volin L, Gurman G, Maertens J, Bordigoni P, Holler E, Ehninger G, Polge E, Gorin NC, Kolb HJ, Rocha V (2007): Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J. Clin. Oncol. 25, 4938-4945.
  • Schmidt AH, Stahr A, Baier D, Schumacher S, Ehninger G, Rutt C (2007): Selective recruitment of stem cell donors with rare human leukocyte antigen phenotypes. Bone Marrow Transplant. 40, 823-830.
  • Platzbecker U, Mohr B, von BM, Binder M, Schetelig J, Ehninger G, Bornhauser M (2007): Lenalidomide as induction therapy before allogeneic stem cell transplantation in a patient with proliferative CMML-2 and del(5q) not involving the EGR1 locus. Leukemia. 21, 2384-2385.
  • Kiani A, Kuithan H, Kuithan F, Kyttala S, Habermann I, Temme A, Bornhauser M, Ehninger G (2007): Expression analysis of nuclear factor of activated T cells (NFAT) during myeloid differentiation of CD34+ cells: regulation of Fas ligand gene expression in megakaryocytes. Exp. Hematol. 35, 757-770.
  • Fierro F, Illmer T, Jing D, Schleyer E, Ehninger G, Boxberger S, Bornhauser M (2007): Inhibition of platelet-derived growth factor receptorbeta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro. Cell Prolif. 40, 355-366.
  • Pabst C, Schirutschke H, Ehninger G, Bornhauser M, Platzbecker U (2007): The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors. Clin. Cancer Res. 13, 2916-2922.
  • Auffermann-Gretzinger S, Eger L, Schetelig J, Bornhauser M, Heidenreich F, Ehninger G (2007): Alemtuzumab depletes dendritic cells more effectively in blood than in skin: a pilot study in patients with chronic lymphocytic leukemia. Transplantation. 83, 1268-1272.
  • Oelschlaegel U, Bornhauser M, Boxberger S, Kroschinsky F, Illmer T, Hoelig K, Calandra G, Ehninger G, Platzbecker U (2007): Kinetics of CXCR-4 and adhesion molecule expression during autologous stem cell mobilisation with G-CSF plus AMD3100 in patients with multiple myeloma. Ann. Hematol. 86, 569-573.
  • Dransfeld CL, Schaich M, Ho AD, Thiede C, Ehninger G, Mahlknecht U (2007): Class I HDAC SNP analysis in healthy donors compared to AML patients. Leukemia. 21, 1587-1590.
  • Freund D, Bauer N, Boxberger S, Feldmann S, Streller U, Ehninger G, Werner C, Bornhauser M, Oswald J, Corbeil D (2006): Polarization of human hematopoietic progenitors during contact with multipotent mesenchymal stromal cells: effects on proliferation and clonogenicity. Stem Cells Dev. 15, 815-829.
  • Florek M, Bauer N, Janich P, Wilsch-Braeuninger M, Fargeas CA, Marzesco AM, Ehninger G, Thiele C, Huttner WB, Corbeil D (2007): Prominin-2 is a cholesterol-binding protein associated with apical and basolateral plasmalemmal protrusions in polarized epithelial cells and released into urine. Cell Tissue Res. 328, 31-47.
  • Platzbecker U, Germing U, Schakel U, Illmer T, Soucek S, Schaich M, Ehninger G, Thiede C (2006): Association with the single-nucleotide polymorphism (Glu785Lys) of the granulocyte colony-stimulating factor receptor with myelodysplastic syndromes and acute myeloid leukemia with multlineage dysplasia. Leukemia. 20, 2188-2189.
  • Bornhauser M, Thiede C, Babatz J, Schetelig J, Illmer T, Kiani A, Platzbecker U, Herr W, Rieber EP, Ehninger G, Schmitz M (2006): Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation. Leukemia. 20, 2055-2057.
  • Kroschinsky F, Holig K, Platzbecker U, Poppe-Thiede K, Ordemann R, Blechschmidt M, Oelschlaegel U, Schaich M, Hanel M, Bornhauser M, Ehninger G (2006): Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma. Transfusion. 46, 1417-1423.
  • *Freund D, Oswald J, Feldmann S, Ehninger G, Corbeil D, Bornhauser M (2006): Comparative analysis of proliferative potential and clonogenicity of MACS-immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor. Cell Prolif. 39, 325-332.
  • Auffermann-Gretzinger S, Eger L, Bornhauser M, Schakel K, Oelschlaegel U, Schaich M, Illmer T, Thiede C, Ehninger G (2006): Fast appearance of donor dendritic cells in human skin: dynamics of skin and blood dendritic cells after allogeneic hematopoietic cell transplantation. Transplantation. 81, 866-873.
  • Thiede C, Koch S, Creutzig E, Steudel C, Illmer T, Schaich M, Ehninger G (2006): Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood. 107, 4011-4020.
  • Platzbecker U, Thiede C, Fussel M, Geissler G, Illmer T, Mohr B, Hanel M, Mahlberg R, Krumpelmann U, Weissinger F, Schaich M, Theuser C, Ehninger G, Bornhauser M (2006): Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia. Leukemia 20, 707-714.
  • Baldus CD, Thiede C, Soucek S, Bloomfield CD, Thiel E, Ehninger G (2006): BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications. J. Clin. Oncol. 24, 790-797.
  • Kroschinsky F, Holig K, Poppe-Thiede K, Zimmer K, Ordemann R, Blechschmidt M, Oelschlaegel U, Bornhauser M, Rall G, Rutt C, Ehninger G (2005): Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors. Haematologica 90, 1665-1671.
  • Strodtbeck D, Bornhauser M, Hanel M, Lerche L, Schaich M, Illmer T, Thiede C, Geissler G, Herbst R, Ehninger G, Platzbecker U (2005): Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission. Bone Marrow Transplant. 36, 1083-1088.
  • Oswald J, Steudel C, Salchert K, Joergensen B, Thiede C, Ehninger G, Werner C, Bornhauser M (2006): Gene-expression profiling of CD34+ hematopoietic cells expanded in a collagen I matrix. Stem Cells 24, 494-500.
  • Schetelig J, Kiani A, Schmitz M, Ehninger G, Bornhauser M (2005): T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation. Cancer Immunol. Immunother. 54, 1043-1058.
  • Illmer T, Thiede C, Fredersdorf A, Stadler S, Neubauer A, Ehninger G, Schaich M (2005): Activation of the RAS pathway is predictive for a chemosensitive phenotype of acute myelogenous leukemia blasts. Clin. Cancer Res. 11, 3217-3224.

 

Artikelaktionen
« Mai 2012 »
Mai
MoDiMiDoFrSaSo
123456
78910111213
14151617181920
21222324252627
28293031


Funding program:

DFG